InvestorsHub Logo
Followers 74
Posts 15841
Boards Moderated 0
Alias Born 04/26/2010

Re: Bluensleepy post# 302851

Sunday, 10/04/2020 12:01:49 PM

Sunday, October 04, 2020 12:01:49 PM

Post# of 426182
GSK's original patent for hypertension expired, Teva file ANDA, started selling the generic, then GSK had a patent re-issued including the CHF indication. Why FDA wouldn't require Hikma to have identical label as V, including R-IT, which they required Teva to do, is not clear to me - that GSK/Teva case is weird. Is it because in that case a patent expired but was replaced with a new one?

The Thought Police: To censor and protect. Craig Bruce

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News